A detailed history of Hilltop National Bank transactions in Repligen Corp stock. As of the latest transaction made, Hilltop National Bank holds 858 shares of RGEN stock, worth $126,065. This represents 0.03% of its overall portfolio holdings.

Number of Shares
858
Previous 835 2.75%
Holding current value
$126,065
Previous $154 Million 29.57%
% of portfolio
0.03%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$120.0 - $182.95 $2,760 - $4,207
23 Added 2.75%
858 $108 Million
Q1 2024

May 06, 2024

BUY
$170.78 - $208.42 $142,601 - $174,030
835 New
835 $154 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Hilltop National Bank Portfolio

Follow Hilltop National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Hilltop National Bank with notifications on news.